Renny, 680 mg+80 mg orange 12 pcs

Pharmaceutical group:

An antacid.

Pharmacidal action:

Renny is a topical antacid.

Contains calcium carbonate and magnesium carbonate which provide fast and prolonged neutralization of excessive hydrochloric acid of gastric juice, thus having protective effect on the gastric mucosa.

Therapeutic effect is achieved within 3-5 min due to good solubility of the tablets and high calcium content.

Indications

Symptoms related to acidity of gastric juice and reflux esophagitis (including those caused by dietary irregularities, medication, alcohol abuse, coffee, nicotine).Including those caused by poor diet, medications, alcohol, coffee, and nicotine abuse): heartburn; sour belching; intermittent stomach pain; feeling of congestion or heaviness in epigastric region; dyspepsia; dyspepsia of pregnant women.

Active ingredient

Composition

Chewable tablets. 1 tablet:

– calcium carbonate 680 mg

– magnesium hydroxycarbonate 80 mg

Supplementary substances:

sucrose (475 mg),

Pregelatinized corn starch,

potato starch,

talc,

magnesium stearate,

light paraffin,

flavoring.

How to take, the dosage

To the mouth, chew or hold in the mouth until completely absorbed.

Adults and children over 12 years of age (unless otherwise recommended by the doctor), 1-2 tablets when symptoms appear.

If necessary, the drug can be repeated after 2 hours.

The maximum daily dose is 11 tablets.

Interaction

Changes in gastric acidity during the use of antacids may lead to a decrease in the rate and degree of absorption of other drugs when taken simultaneously, so the drugs should be taken 1-2 hours before or after taking antacid drugs.

Tetracycline antibiotics, fluoroquinolones, cardiac glycosides, levothyroxine, iron drugs, fluorides, phosphates – when used simultaneously, antacids reduce absorption of these drugs.

Tiazide diuretics – when concomitant use with antacids the calcium concentration in serum should be monitored regularly. Anticholinergic drugs increase and prolong the effect by delaying gastric emptying.

Special Instructions

When prescribing the drug in patients with impaired renal function, serum magnesium, phosphorus and calcium concentrations should be monitored regularly.

Patients with impaired renal function should not take the drug for a long time in high doses.

The use of Renny® in high doses may increase the risk of formation of kidney stones.

If use of the drug is ineffective, a physician should be consulted.

Contraindications

High sensitivity to the drug components; severe renal failure; hypercalcemia; hypophosphatemia; nephrocalcinosis; children under 12 years of age.

Side effects

The drug is well tolerated if the recommended doses are followed, however, in very rare cases, allergic reactions – rash, Quincke’s edema, anaphylactic reactions – are possible.

Overdose

Symptoms: Prolonged use of the drug in high doses in patients with impaired renal function may cause hypermagnesemia, hypercalcemia, alkalosis manifested by nausea, vomiting, muscle weakness.

Treatment: The drug should be discontinued and a physician should be seen immediately.

Similarities